[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":152600000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":300000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":300000.0,"MarketableSecuritiesCurrent_0_Q2_USD":875300000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_2_Q2_USD":0.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":70700000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":82600000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":51800000.0,"OtherLiabilitiesCurrent_0_Q2_USD":41400000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":50000000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_2_Q2_USD":0.0,"ProceedsFromLinesOfCredit_2_Q2_USD":0.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":1009400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":685400000.0,"OtherAssetsCurrent_0_Q2_USD":72000000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":100000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":11300000.0,"LinesOfCreditCurrent_0_Q2_USD":0.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":42900000.0,"EarningsPerShareDiluted_1_Q2_USD":2.41,"EarningsPerShareDiluted_2_Q2_USD":5.53,"ProceedsFromStockOptionsExercised_2_Q2_USD":22400000.0,"InvestmentIncomeInterest_2_Q2_USD":17200000.0,"InvestmentIncomeInterest_1_Q2_USD":7200000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":25000000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":245800000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":12100000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":1400000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":256900000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":108500000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2105100000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":1100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":44100000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":3500000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":15100000.0,"TreasuryStockCommonShares_0_Q2_shares":26619216.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":2500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":718300000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":362000000.0,"ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_2_Q2_USD":14200000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":708300000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":2500000.0,"PaymentsToAcquireLongtermInvestments_2_Q2_USD":0.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":1094300000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":3500000.0,"OtherNoncashIncomeExpense_2_Q2_USD":13900000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":200000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-300000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":35800000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-800000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":1100000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"LongTermLineOfCredit_0_Q2_USD":800000000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":27900000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":18900000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":-41900000.0,"GoodwillGross_0_Q2_USD":28000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-53000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":1852800000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q2_USD":843400000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q2_USD":838600000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":1833800000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":100000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":19100000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":11300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":44000000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":0.0,"OtherAssetsNoncurrent_0_Q2_USD":167400000.0,"StockholdersEquity_0_Q2_USD":3093700000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":3569200000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":744200000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":31200000.0,"NetIncomeLoss_2_Q2_USD":244800000.0,"NetIncomeLoss_1_Q2_USD":107100000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":378600000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-403000000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-28600000.0,"LiabilitiesCurrent_0_Q2_USD":255000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":4219400000.0,"Liabilities_0_Q2_USD":1125700000.0,"InventoryNet_0_Q2_USD":89700000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":20600000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"IncomeTaxExpenseBenefit_2_Q2_USD":60700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":305500000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":133900000.0,"CostsAndExpenses_2_Q2_USD":411100000.0,"CostsAndExpenses_1_Q2_USD":221500000.0,"CommonStockValue_0_Q2_USD":700000.0,"CommonStockSharesOutstanding_0_Q2_shares":44356848.0,"CommonStockSharesIssued_0_Q2_shares":70976064.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":685400000.0,"AssetsCurrent_0_Q2_USD":1894400000.0,"Assets_0_Q2_USD":4219400000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7400000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7200000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-2100000.0,"AccountsReceivableNetCurrent_0_Q2_USD":172000000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":26800000.0,"CommonStockSharesAuthorized_0_Q2_shares":245000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":5400000.0,"IncomeTaxesPaidNet_2_Q2_USD":44000000.0,"NonoperatingIncomeExpense_2_Q2_USD":-1700000.0,"NonoperatingIncomeExpense_1_Q2_USD":-6600000.0,"Goodwill_0_Q2_USD":28000000.0,"EarningsPerShareBasic_2_Q2_USD":5.56,"EarningsPerShareBasic_1_Q2_USD":2.43,"CostOfGoodsAndServicesSold_1_Q2_USD":25900000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":49300000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":6900000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":500000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-8200000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-10600000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":2600000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.2,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":44400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":44300000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":22400000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":158200000.0,"InterestExpense_1_Q2_USD":5600000.0,"InterestExpense_2_Q2_USD":13800000.0,"InterestPaidNet_2_Q2_USD":12400000.0,"OperatingIncomeLoss_1_Q2_USD":140500000.0,"OperatingIncomeLoss_2_Q2_USD":307200000.0,"TreasuryStockCommonValue_0_Q2_USD":2579200000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":89700000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":162900000.0,"ShareBasedCompensation_2_Q2_USD":82600000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":21700000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"Ticker":"UTHR","CIK":"1082554","name":"UNITED THERAPEUTICS CORP","OfficialName":"United Therapeutics Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8315138472.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200729"}]